Benedetta Pessina

Dr. Benedetta Pessina

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2022 in Pediatric Diabetes
Verified
Journal Article
Closed access
BPbarbara piccini
barbara piccini
Benedetta PessinaBenedetta Pessina
Benedetta Pessina
ECEmilio Casalini
Emilio Casalini
LLLorenzo Lenzi
Lorenzo Lenzi
STSonia Toni
Sonia Toni

13 March 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
LTLeonardo Tomei
Leonardo Tomei
AMAntonella Muraro
Antonella Muraro
MGMattia Giovannini
Mattia Giovannini
SBsimona barni
simona barni
GLGiulia Liccioli
Giulia Liccioli
Francesca MoriFrancesca Mori
Francesca Mori
In food allergy management, the avoidance of the allergen that caused the reaction plays a fundamental role. Nevertheless, that can be thwarted in case of accidental exposure to a rare or hidden allergen, causing the adoption of a monotonous diet and a consequent reduction in the quality of life of the patient and their family. The identification of a rare and hidden allergen is an important diagnostic challenge, taking into account that a significant proportion of all food reactions is in reality due to them. The aim of the present review is to provide the pediatric allergist an overview of the possible sources of rare and hidden food allergens, taking into consideration the routes of exposure to these potential allergens with the main examples published in the scientific literature and the distinction between types of direct or cross-contamination. The identification of the allergen responsible for the reaction and the provision of a dietary advice customized for the specific individual’s dietary habits is essential to improve quality of life of the familiar nucleus and to reduce the risk of further allergic reactions.

7 June 2022 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Open access
SCStefano Cavalieri
Stefano Cavalieri
Benedetta PessinaBenedetta Pessina
Benedetta Pessina
GIGiuseppe Indolfi
Giuseppe Indolfi
LGLuisa Galli
Luisa Galli
STSandra Trapani
Sandra Trapani
Background: Pediatric spondylodiscitis is rare, hardly diagnosed and treated due to the nonspecificity of clinical presentation and laboratory investigations, difficulty of etiologic identification and lack of management guidelines. Methods: A retrospective study was conducted on 29 children with spondylodiscitis. Clinical, hematic and radiologic data were collected and compared between 2 age-subgroups (below and from 4 years old on) to investigate age-related differences. Epidemiologic, management and follow-up data were also described. Results: Slight male predominance and a peak of incidence <2 years were observed. Symptoms were significantly differently distributed in the 2 age-subgroups: children 2 months was always associated with multivertebral involvement and complications. All children were treated with broad-spectrum antibiotics for a median of 12 weeks. Only in 1 complicated case, surgical treatment was also required. Conclusions: The clinical presentation of spondylodiscitis may be age-specific, with younger children often exhibiting subtle signs and symptoms. Broad-spectrum antibiotics covering for Staphylococcus aureus should be initiated as soon as possible and performed many weeks, being effective in treating the infection without clinical sequelae, even in patients with comorbidities. Surgical treatment should be reserved for complicated cases with neurologic involvement.

30 December 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
SBsimona barni
simona barni
Benedetta PessinaBenedetta Pessina
Benedetta Pessina
LFLorenzo Fioretti
Lorenzo Fioretti
LSLuca Scarallo
Luca Scarallo
ASAndrea Di Siena
Andrea Di Siena
Francesca MoriFrancesca Mori
Francesca Mori
Background/Objectives: Food protein-induced allergic proctocolitis (FPIAP) is a non-IgE-mediated food allergy, usually presenting as bloody stools in breastfed, well-appearing, and regularly growing infants. The aim of our study was to describe the clinical features of Italian infants affected by FPIAP and their management and natural history in a real-life setting. Methods: A retrospective, observational study was performed at two tertiary pediatric hospitals (Florence and Trieste), including FPIAP-diagnosed infants between 2012 and 2022. Results: Most of the 100 enrolled patients were breastfed (68.0%), and the majority of those who underwent diagnostic tests (n = 51) showed normal hemoglobin and total IgE levels. A maternal elimination diet was performed in 69.0%, mostly for milk only, but 40.6% underwent multiple elimination diets. The remission rate was high both in breastfed infants (76.8%) and in those who received extensively hydrolyzed formula (81.8%). Nine subjects were left on a free diet, but six were lost at follow-up. The median time of complete remission was 30 days (IQR 14–60). Culprit food reintroduction was tolerated at a median age of 8 months (IQR 6–11), in ladder modality (for hen’s egg and cow’s milk) in 61.7%. Nine patients relapsed (14.3%) upon reintroduction with no associated variables identified at the regression analysis. The relapse rate was slightly higher when trigger food reintroduction was attempted > 12 months (16.7%) versus <12 months (13.0%). Conclusions: In our population, FPIAP had, as expected, a benign evolution. The early reintroduction of the suspect food in a gradual manner for cow’s milk and hen’s egg leads to good tolerance within the first year in most patients, avoiding unnecessary elimination diets.

7 February 2024 in World Allergy Organization Journal
Verified
Journal Article
Open access
Francesca MoriFrancesca Mori
Francesca Mori
GLGiulia Liccioli
Giulia Liccioli
LTLeonardo Tomei
Leonardo Tomei
SBsimona barni
simona barni
MGMattia Giovannini
Mattia Giovannini
MTMaría J Torres
María J Torres
The majority of viral rashes occurring during an antibiotic therapy are considered as a drug hypersensitivity reaction (DHR). Differentiating a viral rash versus a DHR is difficult or even impossible. In delayed DHRs the interplay between viruses and drugs is summarized according to the recent literature. The question is if the same reaction will again occur in case of drug re-exposure in absence of the concomitant viral infection because of persistent immune reactivity. Epstein Barr Virus (EBV) and Human Herpes virus 6 (HHV-6) models are analyzed in case of maculopapular exanthemas (MPEs) and drug reaction with eosinophilia and systemic symptoms (DRESS) over a course of drug therapy. MPEs are the most common skin manifestation during a viral infection and a concomitant drug therapy. In type IVb reactions to drugs a hapten/pro-hapten mechanism and a pharmacological interaction (p-i mechanism) are described as the 2 major ways to make T cells response functional. Rarely the altered repertoire model is involved. The Human Leukocyte Antigen (HLA) predisposition is an additional essential factor that can facilitate DHR. In MPEs rarely a DHR is confirmed by allergy testing. Severity and duration of MPEs, the presence of eosinophilia and systemic symptoms make more reliable the persistent nature of the reaction. Research on this topic is needed in order to provide the clinicians with instruments to decide when to suspect future reactions upon drug re-exposure even in the absence of a viral infection, because those patients should be investigated by a complete drug allergy work up.

7 September 2023 in Frontiers in Pediatrics
Verified
Journal Article
Open access
FSFrancesca Saretta
Francesca Saretta
MGMattia Giovannini
Mattia Giovannini
Benedetta PessinaBenedetta Pessina
Benedetta Pessina
SBSimona Barni
Simona Barni
GLGiulia Liccioli
Giulia Liccioli
FMFrancesca Mori
Francesca Mori
Venom immunotherapy protocols in the pediatric population: how to choose?